Clinical Trial Update: Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users [Phase 2]

View source ↗

Summary

Phase 2 study assessing a transdermal patch containing ethinyl estradiol and norelgestromin to address irregular bleeding in contraceptive implant users; the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abnormal Uterine Bleeding
• Menstrual Disorders
• Metrorrhagia
• Uterine Hemorrhage

Drugs mentioned

• Norelgestromin (norelgestromin)
• ethinyl estradiol (ethinyl estradiol)

Snippet

Sponsor: Chulalongkorn University | Conditions: Menstruation Disturbances, Metrorrhagia | Phase 2 | Status: RECRUITING